Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Platelet-rich fibrin (PRF) membrane is an autologous biologic material used in regenerative dentistry and oral surgery. It is prepared chairside from the patient's own blood through a single-step centrifugation process without the addition of anticoagulants or bovine thrombin. The resulting fibrin matrix traps platelets, leukocytes, and cytokines, acting as a scaffold that provides a sustained release of growth factors, including platelet-derived growth factor (PDGF), transforming growth factor-beta (TGF-β), and vascular endothelial growth factor (VEGF). In the context of clinical research at Kafrelsheikh University, it is being evaluated for its efficacy in improving the periodontal phenotype—specifically gingival thickness and the width of keratinized tissue—around dental implants in the upper anterior region, compared to fascia lata allografts and subepithelial connective tissue grafts.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on platelet-rich fibrin membrane-Kafrelsheikh University.